BARCLAYS PLC - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 49 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$45
-47.7%
6,211
-57.4%
0.00%
Q1 2024$86
-59.0%
14,594
-49.0%
0.00%
Q4 2023$210
+1400.0%
28,640
+688.5%
0.00%
Q3 2023$14
-41.7%
3,632
-12.9%
0.00%
Q2 2023$24
-78.2%
4,172
-75.3%
0.00%
Q1 2023$110
-99.4%
16,922
+696.3%
0.00%
Q1 2022$17,000
-94.2%
2,125
-93.3%
0.00%
Q4 2021$292,000
+335.8%
31,792
+494.0%
0.00%
Q3 2021$67,000
+235.0%
5,352
+213.5%
0.00%
Q2 2021$20,000
-87.3%
1,707
-83.6%
0.00%
Q1 2021$157,000
+241.3%
10,399
+159.0%
0.00%
Q4 2020$46,000
+4.5%
4,015
-30.4%
0.00%
Q3 2020$44,000
-42.1%
5,767
-16.4%
0.00%
Q2 2020$76,000
+65.2%
6,902
+61.5%
0.00%
Q1 2020$46,000
-77.6%
4,274
-66.9%
0.00%
Q4 2019$205,000
+118.1%
12,895
+102.9%
0.00%
Q3 2019$94,000
-3.1%
6,356
-23.5%
0.00%
Q2 2019$97,000
+94.0%
8,309
+81.9%
0.00%
Q1 2019$50,000
+42.9%
4,568
+110.2%
0.00%
Q3 2018$35,0002,1730.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Propel Bio Management, LLC 424,937$3,097,7912.01%
Perceptive Advisors 7,099,182$51,753,0371.25%
BML Capital Management, LLC 180,000$1,312,2000.94%
Avoro Capital Advisors LLC 3,999,999$29,159,9930.39%
Simplify Asset Management Inc. 280,000$2,041,2000.14%
EAM Investors, LLC 70,586$514,5720.08%
SteelPeak Wealth, LLC 122,836$895,4750.04%
SPC Financial, Inc. 30,000$218,7000.02%
Key FInancial Inc 9,415$68,6350.02%
Miracle Mile Advisors, LLC 84,000$612,3600.02%
View complete list of VERRICA PHARMACEUTICALS INC shareholders